Table 1.
Activities of antimicrobial agents against 151 Nocardia isolates
Bacterium (no of isolates tested) and antimicrobial agent | MIC (μg/ml) |
Susceptibility (%)a |
||||
---|---|---|---|---|---|---|
Range | 50% | 90% | S | I | R | |
N. brasiliensis (60) | ||||||
Amoxicillin-clavulanic acid | 0.5–32 | 1 | 2 | 59 (98) | 1 (2) | |
Cefoxitin | 1–>128 | 2 | 8 | |||
Ceftriaxone | 0.5–32 | 2 | 4 | 57 (95) | 3 (5) | 0 (0) |
Meropenem | 0.5–8 | 2 | 4 | |||
Ertapenem | 0.25–8 | 4 | 8 | |||
Imipenem | 0.5–>32 | 2 | >32 | 28 (47) | 3 (5) | 29 (48) |
Doripenem | 0.5–8 | 2 | 4 | |||
Azithromycin | 16–>128 | 32 | >128 | |||
Ciprofloxacin | 0.5–8 | 8 | 8 | 1 (2) | 0 (0) | 59 (98) |
Nemonoxacin | 0.12–1 | 0.25 | 0.5 | |||
Gemifloxacin | 0.06–2 | 0.25 | 0.5 | |||
Levofloxacin | 1–>16 | 4 | 8 | |||
Moxifloxacin | 0.12–2 | 1 | 1 | |||
Linezolid | 1–16 | 4 | 8 | 59 (98) | 1 (2) | |
Vancomycin | 0.5–>128 | 128 | >128 | |||
Daptomycin | 64–>128 | 128 | >128 | |||
Sulfamethoxazole | 0.5–64 | 4 | 8 | 59 (98) | 1 (2) | |
Amikacin | 0.25–4 | 1 | 2 | 60 (100) | 0 (0) | |
Tigecycline | 0.25–1 | 0.25 | 1 | |||
N. cyriacigeorgica (24) | ||||||
Amoxicillin-clavulanic acid | 4–16 | 16 | 16 | 9 (38) | 14 (58) | 1 (4) |
Cefoxitin | 0.12–>16 | 4 | 16 | |||
Ceftriaxone | 0.25–16 | 2 | 8 | 23 (96) | 1 (4) | 0 (0) |
Meropenem | 1–4 | 4 | 4 | |||
Ertapenem | 2–8 | 4 | 8 | |||
Imipenem | 0.5–>4 | 1 | 2 | 24 (100) | 0 (0) | 0 (0) |
Doripenem | 1–8 | 4 | 4 | |||
Azithromycin | 128–>128 | >128 | >128 | |||
Ciprofloxacin | 0.12–128 | 16 | 64 | 0 (0) | 0 (0) | 24 (100) |
Nemonoxacin | 0.25–2 | 1 | 2 | |||
Gemifloxacin | 2–8 | 2 | 4 | |||
Levofloxacin | 8–>32 | 16 | 32 | |||
Moxifloxacin | 2–4 | 4 | 4 | |||
Linezolid | 2–16 | 4 | 4 | 23 (96) | 1 (4) | |
Vancomycin | 16–>128 | 128 | >128 | |||
Daptomycin | 128–>128 | 128 | >128 | |||
Sulfamethoxazole | 2–16 | 4 | 4 | 24 (100) | 0 (0) | |
Amikacin | 0.5–2 | 1 | 2 | 24 (100) | 0 (0) | |
Tigecycline | 0.5–4 | 2 | 4 | |||
N. farcinica (12) | ||||||
Amoxicillin-clavulanic acid | 0.5–8 | 1 | 4 | 12 (100) | 0 (0) | 0 (0) |
Cefoxitin | 0.5–>128 | 32 | >128 | |||
Ceftriaxone | 1–>64 | 32 | 64 | 3 (25) | 5 (42) | 4 (33) |
Meropenem | 0.5–>8 | 4 | 4 | |||
Ertapenem | 0.5–>8 | 8 | 8 | |||
Imipenem | 0.25–>4 | 1 | 2 | 12 (100) | 0 (0) | 0 (0) |
Doripenem | 0.25–>4 | 4 | 4 | |||
Azithromycin | 128–>128 | >128 | >128 | |||
Ciprofloxacin | 0.5–128 | 8 | 16 | 6 (50) | 1 (8) | 5 (42) |
Nemonoxacin | 0.03–1 | 0.25 | 1 | |||
Gemifloxacin | 0.03–2 | 0.12 | 0.5 | |||
Levofloxacin | 0.12–16 | 4 | 8 | |||
Moxifloxacin | 0.06–8 | 1 | 2 | |||
Linezolid | 1–4 | 4 | 4 | 12 (100) | ||
Vancomycin | 2–>128 | 128 | >128 | |||
Daptomycin | 64–>128 | 128 | >128 | |||
Sulfamethoxazole | 2–64 | 8 | 32 | 11 (92) | 1 (8) | |
Amikacin | 1–4 | 1 | 4 | 12 (100) | 0 (0) | |
Tigecycline | 0.25–8 | 1 | 8 | |||
N. beijingensis (9) | ||||||
Amoxicillin-clavulanic acid | 1–32 | 4 (44) | 4 (44) | 1 (11) | ||
Cefoxitin | 1–>4 | |||||
Ceftriaxone | 0.25–16 | 7 (78) | 2 (22) | 0 (0) | ||
Meropenem | 0.25–2 | |||||
Ertapenem | 2–4 | |||||
Imipenem | 0.5–>8 | 5 (56) | 4 (44) | |||
Doripenem | 1–2 | |||||
Azithromycin | 64–>128 | |||||
Ciprofloxacin | 2–128 | 0 (0) | 4 (44) | 5 (56) | ||
Nemonoxacin | 0.5–8 | |||||
Gemifloxacin | 0.25–16 | |||||
Levofloxacin | 4–16 | |||||
Moxifloxacin | 1–32 | |||||
Linezolid | 2–4 | 9 (100) | ||||
Vancomycin | 128–>128 | |||||
Daptomycin | 64–>>128 | |||||
Sulfamethoxazole | 1–4 | 9 (100) | 0 (0) | |||
Amikacin | 0.12–0.5 | 8 (89) | 1 (11) | |||
Tigecycline | 0.12–8 | |||||
N. otitidiscaviarum (8) | ||||||
Amoxicillin-clavulanic acid | 32–128 | 0 (0) | 0 (0) | 8 (100) | ||
Cefoxitin | 64–>128 | |||||
Ceftriaxone | 16–>128 | 0 (0) | 1 (13) | 7 (87) | ||
Meropenem | 4–>32 | |||||
Ertapenem | 16–>32 | |||||
Imipenem | 16–>32 | 0 (0) | 0 (0) | 8 (100) | ||
Doripenem | 4–>32 | |||||
Azithromycin | 0.5–>128 | |||||
Ciprofloxacin | 2–16 | 0 (0) | 3 (37) | 5 (63) | ||
Nemonoxacin | 0.5–2 | |||||
Gemifloxacin | 0.5–4 | |||||
Levofloxacin | 1–8 | |||||
Moxifloxacin | 0.25–4 | |||||
Linezolid | 2–4 | 8 (100) | ||||
Vancomycin | 128–>128 | |||||
Daptomycin | 64–128 | |||||
Sulfamethoxazole | 4–32 | 8 (100) | 0 (0) | |||
Amikacin | 0.5–4 | 8 (100) | 0 (0) | |||
Tigecycline | 0.5–2 | |||||
N. nova (8) | ||||||
Amoxicillin-clavulanic acid | 8–64 | 1 (13) | 3 (38) | 4 (50) | ||
Cefoxitin | 2–16 | |||||
Ceftriaxone | 2–16 | 7 (87) | 1 (13) | 0 (0) | ||
Meropenem | 0.12–2 | |||||
Ertapenem | 0.5–4 | |||||
Imipenem | 0.03–1 | 8 (100) | 0 (0) | 0 (0) | ||
Doripenem | 0.25–2 | |||||
Azithromycin | 0.25–>128 | |||||
Ciprofloxacin | 4–16 | 0 (0) | 0 (0) | 8 (100) | ||
Nemonoxacin | 0.25–1 | |||||
Gemifloxacin | 0.5–2 | |||||
Levofloxacin | 2–>32 | |||||
Moxifloxacin | 0.5–4 | |||||
Linezolid | 12 | 8 (100) | ||||
Vancomycin | 32–>128 | |||||
Daptomycin | 64–>128 | |||||
Sulfamethoxazole | 4–32 | 8 (100) | 0 (0) | |||
Amikacin | 0.12–32 | 7 (87) | 1 (13) | |||
Tigecycline | 0.25–8 | |||||
N. asiatica (7) | ||||||
Amoxicillin-clavulanic acid | 16–64 | 0 (0) | 1 (14) | 6 (86) | ||
Cefoxitin | 0.5–2 | |||||
Ceftriaxone | 0.5–1 | 7 (100) | 0 (0) | 0 (0) | ||
Meropenem | 0.5–2 | |||||
Ertapenem | 1–4 | |||||
Imipenem | 0.5–1 | 7 (100) | 0 (0) | 0 (0) | ||
Doripenem | 1–2 | |||||
Azithromycin | >128 | |||||
Ciprofloxacin | 64–128 | 0 (0) | 0 (0) | 7 (100) | ||
Nemonoxacin | 16 | |||||
Gemifloxacin | 16–32 | |||||
Levofloxacin | >32 | |||||
Moxifloxacin | 1–32 | |||||
Linezolid | 1–4 | 7 (100) | ||||
Vancomycin | 128–>128 | |||||
Daptomycin | 128–>128 | |||||
Sulfamethoxazole | 2–8 | 7 (100) | 0 (0) | |||
Amikacin | 0.12–0.25 | 7 (100) | 0 (0) | |||
Tigecycline | 0.25–1 | |||||
N. puris (6) | ||||||
Amoxicillin-clavulanic acid | 16 | 0 (0) | 6 (100) | 0 (0) | ||
Cefoxitin | 128–>128 | |||||
Ceftriaxone | 4–>128 | 1 (17) | 0 (0) | 5 (83) | ||
Meropenem | 2–4 | |||||
Ertapenem | 4–8 | |||||
Imipenem | 1–2 | 6 (100) | 0 (0) | 0 (0) | ||
Doripenem | 2–4 | |||||
Azithromycin | 4–>128 | |||||
Ciprofloxacin | 8 | 0 (0) | 0 (0) | 6 (100) | ||
Nemonoxacin | 0.5 | |||||
Gemifloxacin | 1 | |||||
Levofloxacin | 4–8 | |||||
Moxifloxacin | 2 | |||||
Linezolid | 2–4 | 6 (100) | ||||
Vancomycin | 0.5–>128 | |||||
Daptomycin | 128–>128 | |||||
Sulfamethoxazole | 0.5–16 | 6 (100) | 0 (0) | |||
Amikacin | 0.12–1 | 6 (100) | 0 (0) | |||
Tigecycline | 0.25–2 | |||||
Other Nocardia spp. (17) | ||||||
Amoxicillin-clavulanic acid | 1–64 | 8 | 32 | 10 (59) | 3 (18) | 4 (24) |
Cefoxitin | 0.12–32 | 4 | 16 | |||
Ceftriaxone | 0.25–8 | 1 | 4 | 17 (100) | 0 (0) | 0 (0) |
Meropenem | 0.12–4 | 1 | 4 | |||
Ertapenem | 0.25–16 | 2 | 8 | |||
Imipenem | 0.12–32 | 0.5 | 2 | 16 (94) | 0 (0) | 1 (6) |
Doripenem | 0.12–4 | 2 | 4 | |||
Azithromycin | 1–>128 | >128 | >128 | |||
Ciprofloxacin | 0.25–128 | 8 | 16 | 4 (24) | 1 (6) | 12 (71) |
Nemonoxacin | 0.12–16 | 1 | 16 | |||
Gemifloxacin | 0.06–32 | 2 | 32 | |||
Levofloxacin | 0.25–>32 | 8 | 16 | |||
Moxifloxacin | 0.25–32 | 4 | 32 | |||
Linezolid | 0.5–4 | 2 | 4 | 17 (100) | ||
Vancomycin | 0.25–>128 | 128 | >128 | |||
Daptomycin | 0.5–>128 | 128 | >128 | |||
Sulfamethoxazole | 4–32 | 4 | 8 | 17 (100) | 0 (0) | |
Amikacin | 0.12–32 | 0.5 | 2 | 16 (94) | 1 (6) | |
Tigecycline | 0.06–4 | 0.5 | 2 |
S, susceptible; I, intermediate; R, resistant.